The Future of Pharma Data, AI, and Drug Development - with Glen de Vries of Medidata
Listen now
Description
Glen de Vries cofounded Medidata in 1999, offering SaaS-based clinical development solutions addressing the functioning of customers' clinical trials, and 20 years later the company - which he still leads - sold to Dassault Systemes for almost $6 billion. What a triumph, Glen! Thank you for joining the podcast. Listen in as Glen shares his unique and valuable perspective on the current state and potential futures for the data ecosystem in Life Sciences. Want to stay on the cutting edge of emerging data-driven technologies? Try out Emerj Plus: emerj.com/p1
More Episodes
Today’s guest is Julie Winkler, Chief Commercial Officer of the CME Group. CME Group is a Chicago-based financial services firm that operates derivative exchanges including the Chicago Mercantile Exchange and Chicago Board of Trade. Julie joins Emerj CEO and Head of Research Daniel Faggella on...
Published 04/25/24
Today’s guest is Matt Berseth, Co-founder and Chief Information Officer of NLP Logix. NLP Logix is a fast-growing AI services firm based in Florida that serves both the public and private sectors. Matt joins us on today’s program to talk about the last decade in AI development and how natural...
Published 04/24/24
Published 04/24/24